Category: Omicron
Japan: new Covid wave begins with BF.5 as leading variant again
Japan is seeing a new wave of coronavirus rolling in, just weeks after the last devastating wave tailed off.… ...More...
BF.7: Another contender for global domination
The XBB and BQ.1 variants have recently been making headlines, but another SARS-CoV-2 variant, BF.7 has been closely tracking their success across the globe.… ...More...
Preprint: Neutralizing antibody escape of BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
A recent preprint looks at the neutralizing antibody escape abilities for several new variants causing concern across the globe.… ...More...
Singapore: XBB variant more prevalent in those without a previous Covid infection
Singapore’s Health Minister, Ong Ye Kung, has said that he expects the current XBB SARS-CoV-2 wave to peak in mid-November 2022. … ...More...
XBB set to become the dominant variant in Singapore
XBB is set to become the dominant variant in Singapore, and is already dominant in Bangladesh.… ...More...
The world’s first XBB wave begins in Singapore
The world’s first wave of the recombinant SARS-CoV-2 variant XBB has apparently begun in Singapore.… ...More...
Denmark: A soup of 120 Covid variants sequenced in one month
You may have heard the expression “a soup of Covid variants” recently..… ...More...
China: Xinjiang Covid epidemic “most difficult major public health emergency in local history”
China’s daily newspaper, the Global Times, is giving prominent coverage today to the ongoing Covid outbreak in Xinjiang, headlining it as the “most difficult major public health emergency in local history”.… ...More...
Multiple hypermutated SARS-CoV-2 sequences that may have been created by molnupiravir
Molnupiravir, a drug used to treat SARS-CoV-2 infections, has received a lot of press attention since its launch, and not all of it has been positive.… ...More...
Growth advantage for BQ.1.1 is above 100% per week
The Omicron variant BQ.1.1 appears to be in a prime position to drive the coming winter wave in Europe.… ...More...